Farache Tostes Nathalia, de Carvalho Beatriz Pereira, Santana Aleixo Isabella Caroline, Souza Nilian Carla, da Cunha Antunes Saraiva Danúbia, Brum Martucci Renata
Post-Graduated Program in Nutrition, Food and Health, Nutrition Institute, Rio de Janeiro State University, Rio de Janeiro, RJ, Brazil.
Post-Graduated Program in Medical Science, Medical Science Faculty, State University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Eur J Pediatr. 2025 Feb 6;184(2):180. doi: 10.1007/s00431-025-06011-0.
Chemotherapy can alter body composition, including loss of skeletal muscle mass and density changes, which are linked to negative outcomes. This study investigates body composition changes in children and adolescents with lymphoma, focusing on the impact of chemotherapy protocols and diagnoses. A retrospective observational study included 49 lymphoma patients (ages 6-18) who underwent chemotherapy from 2017 to 2021, excluding palliative care cases. Data on disease, treatment, weight, and height were collected, and anthropometric indices, Body Mass Index by Age (BMI/A) and height by age (H/A) were calculated. Body composition was analyzed using Computed tomography (CT) at the third lumbar vertebra region (L3) with Slice-O-Matic 5.0 software, measuring skeletal muscle area (SMA), skeletal muscle density (SMD) measured in Hounsfield units (HU), total psoas muscle area (PMA), subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT), and intramuscular adipose tissue (IMAT). Paired t-tests compared variables before and after treatment, and the delta of body composition parameters was stratified by chemotherapy protocols and diagnoses (Kruskal-Wallis Test), considering p < 0.05 as significant. Forty-nine patients were included (mean age 13.24 years, 49% male). After chemotherapy, there was an increase in SAT, VAT, IMAT, and SMA (p < 0.001), while SMD decreased from 41 HU to 35.27 HU (p < 0.001). The EURONET protocol and Hodgkin lymphoma were associated with increases in SAT (∆ = 78.28 cm/73.92 cm) and VAT (∆ = 27.44 cm/26.36 cm).
Significant adipose tissue gains were observed in the EURONET protocol and Hodgkin lymphoma, highlighting the impact of chemotherapy on body composition.
• Computed tomography is used to assess body composition, including muscle, adipose tissue and muscle density in adults. • Chemotherapy treatment negatively affects body composition, reducing muscle mass in adults with cancer.
• Computed tomography can also be used to assess body composition in children and adolescents with cancer. • In pediatrics, chemotherapy can also impact body composition, with changes varying according to the administered protocol.
化疗会改变身体成分,包括骨骼肌质量的减少和密度变化,这些都与不良后果相关。本研究调查淋巴瘤患儿和青少年的身体成分变化,重点关注化疗方案和诊断的影响。一项回顾性观察研究纳入了49例2017年至2021年接受化疗的淋巴瘤患者(年龄6 - 18岁),排除姑息治疗病例。收集了疾病、治疗、体重和身高数据,并计算了人体测量指数、年龄别体重指数(BMI/A)和年龄别身高(H/A)。使用Slice - O - Matic 5.0软件在第三腰椎区域(L3)通过计算机断层扫描(CT)分析身体成分,测量骨骼肌面积(SMA)、以亨氏单位(HU)测量的骨骼肌密度(SMD)、腰大肌总面积(PMA)、皮下脂肪组织(SAT)、内脏脂肪组织(VAT)和肌内脂肪组织(IMAT)。配对t检验比较治疗前后的变量,身体成分参数的变化量按化疗方案和诊断进行分层(Kruskal - Wallis检验),以p < 0.05为有统计学意义。纳入49例患者(平均年龄13.24岁,49%为男性)。化疗后,SAT、VAT、IMAT和SMA增加(p < 0.001),而SMD从41 HU降至35.27 HU(p < 0.001)。EURONET方案和霍奇金淋巴瘤与SAT(∆ = 78.28 cm²/73.92 cm²)和VAT(∆ = 27.44 cm²/26.36 cm²)的增加有关。
在EURONET方案和霍奇金淋巴瘤中观察到显著脂肪组织增加,突出了化疗对身体成分的影响。
• 计算机断层扫描用于评估成人的身体成分,包括肌肉、脂肪组织和肌肉密度。• 化疗治疗对身体成分有负面影响,会减少癌症成人患者的肌肉质量。
• 计算机断层扫描也可用于评估癌症患儿和青少年的身体成分。• 在儿科,化疗也会影响身体成分,其变化因所采用的方案而异。